LONG MINI-FUTURE - AMGEN | Delayed Deutsche Boerse AG 11:02:39 2024-06-13 am EDT | ||
| 9.88 EUR | -2.95% |
|
| Current month | -3.23% | ||
| 1 month | -8.94% |
Comparison chart between the derivative product and it's underlying value
End-of-day quotes
Chart
AMGEN INC.
Latest news about AMGEN INC.
More news
| Date | Price | Change |
|---|---|---|
| 24-06-13 | 9.88 | -2.95% |
| 24-06-12 | 10.18 | -0.78% |
| 24-06-11 | 10.26 | -2.10% |
| 24-06-10 | 10.48 | -2.15% |
| 24-06-07 | 10.71 | +1.42% |
Delayed Quote Deutsche Boerse AG
Last update June 13, 2024 at 11:02 am EDT
More quotesStatic data
| Product type | Knock-Out with Stop Loss |
|---|---|
| Buy / Sell | CALL |
| Underlying | AMGEN INC. |
| Issuer | 
Vontobel
|
| WKN | VV16X9 |
| ISIN | DE000VV16X94 |
| Date issued | 2022-05-06 |
| Strike | 191.1 $ |
| Maturity | Unlimited |
| Parity | 10 : 1 |
| Emission price | 5.84 € |
| Emission volume | N/A |
| Settlement | cash |
| Currency | EUR |
Technical Indicators
| Highest since issue | 12.92 € |
|---|---|
| Lowest since issue | 3.15 € |
| Spread | 0.02 € |
| Spread % | 0.20% |
Company Profile
Amgen Inc. is one of the world's leading biotechnology groups. Net sales break down by source of revenue as follows:
- drug sales (94.2%): drugs for treating cancer, metabolic disorders, bone diseases, renal failure, hemophilia, etc.;
- other (5.8%): primarily royalties.
The United States account for 70.3% of net sales.
Sector
-
Consensus: Amgen Inc.
Sell
Buy
Mean consensus
OUTPERFORM
Number of Analysts
30
Last Close Price
301.1
USD
Average target price
316.3
USD
Spread / Average Target
+5.05%
- Stock Market
- Certificates
- Certificat
